List view / Grid view

Shawn Davis (AstraZeneca)

Filter the results

 

article

Alternative routes of administration – a focus on oral biologics

A major challenge in achieving clinically relevant oral delivery of…

28 October 2020 | By

A major challenge in achieving clinically relevant oral delivery of biologics is overcoming the multiple physiological barriers in the gastrointestinal tract. In this article Nikki Withers discusses these challenges with Shawn Davis, Head of Drug Delivery, BioPharmaceuticals Development, R&D at AstraZeneca, who shares some of the latest advances in drug…